 Glen Rock, N.J., Dec. 14, 2021 GLOBE NEWSWIRE -- RespireRx Pharmaceuticals Inc. OTCQB: RSPI RespireRx or the Company, with a mission to discover and develop innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that its Chief Financial Officer, Jeff Margolis, will be presenting at the Life Sciences Virtual Investor Conference LSVIC on December 16, 2021 at 10:00 am EST, and its President and CEO, Tim Jones will be presenting via pre-recorded video at the virtual Biotech ShowcaseTM taking place January 17 19, 2022. 